JPRN-jRCTs031180044
Recruiting
Phase 2
The study of novel therapy for patients who have intractable diarrhea symptoms by the bile acid sequestrants - The study of novel therapy for patients who have intractable diarrhea symptoms by the bile acid sequestrants
Misawa Noboru0 sites50 target enrollmentNovember 27, 2018
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Misawa Noboru
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients who are diagnosed IBS\-D or functional diarrhea by ROME criteria and have treatment for the diarrhea within 4 weeks before entry
- •(2\) Patients who have more than three defecation or more than bristol score 6 per day
- •(3\) Patients who are excluded mechanical disorders by colonoscopy within five years
- •(4\) Patients who are 20 years old or over and under 80
Exclusion Criteria
- •(1\) Patients who have severe complications
- •(2\) Patients who had colestimide within 4 weeks before entry
- •(3\) Patients who have history of colestimide allergies
- •(4\) Patients who are biliary obstruction
- •(5\) Patients who are intestinal obstruction
- •(6\) Patients who have narrowing of colon lumen
- •(7\) Patients who have diverticular disease of intestine
- •(8\) Patients who have difficulty of swallowing
- •(9\) Patients who have hemorrhoid
- •(10\) Patients who have or had gastrointestinal ulcer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluating a new treatment regimen for patients with multidrug-resistant TB (MDR-TB)HIV/AIDSTuberculosisPACTR201409000848428university of Cape Town Lung Institute256
Not yet recruiting
Not Applicable
A study on fever using therapeutics of fever by H C AlleHealth Condition 1: G969- Disorder of central nervous system, unspecifiedCTRI/2024/03/063748Sarada Krishna Homoeopathic medical college
Active, not recruiting
Not Applicable
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
Completed
Not Applicable
Clinical trial aimed at new therapeutic strategy for HAM by prosultiamine treatment with oral administratioHTLV-I associated myelopathy (HAM)JPRN-UMIN000005969The Department of Molecular Microbiology and Immunology25
Completed
Not Applicable
Clinical study on alternative treatment of patients with second stage Trypanosoma brucei gambiense sleeping sicknessTrypanosoma brucei gambiense Human African Trypanosomiasis in second stageInfections and InfestationsAfrican trypanosomiasisISRCTN36877262Institute of Tropical Medicine (Belgium)600